Medical/Pharmaceuticals News & Press Release Distribution

Baxter, a global leader in Dialysis Care, reaffirms its commitment to equitable access to care on World Kidney Day

BANGKOK, March 11, 2021 /PRNewswire/ -- Baxter, a global leader in dialysis care, is proud to support this year'sWorld Kidney Day , under the theme "Living Well with Kidney Disease". Kidney disease affects approximately 10% of the global population, and in T...

2021-03-11 09:30 1912

Baxter Announces New Data on Benefits of Remote Patient Management for Home Peritoneal Dialysis World Kidney Day 11 March 2021

* Published economic modelling shows estimated reduction in hospital episodes and potential financial savings from remote patient monitoring technology. * Baxter supports World Kidney Day Steering Committee in declaring 2021 the year of "Living Well with Kidney Disease". SINGAPORE, March 11, 2...

2021-03-11 09:30 3088

Baxter, a global partner of World Kidney Day welcomes new guidance issued by Vietnam Ministry of Health for End Stage Renal Disease (ESRD) Patients

HANOI, Vietnam, March 11, 2021 /PRNewswire/ -- Baxter, a global leader in dialysis care, is proud to support this year'sWorld Kidney Day , under the theme "Living Well with Kidney Disease". Kidney disease affects approximately 10% of the global population, and...

2021-03-11 09:30 1963

Ascentage Pharma to Present the Latest Results from Six Preclinical Studies at AACR Annual Meeting 2021

SUZHOU, China and ROCKVILLE, Md., March 11, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the latest preclinical...

2021-03-11 08:35 2564

First pocket inhaler for Covid-19 and other viral mutations: DG-Nika AG - a new approach to therapy & proactive protection from the pandemic

BUOCHS, Switzerland, March 11, 2021 /PRNewswire/ -- The corona pandemic continues to pose a global threat: To date, it has been possible to vaccinate only a small fraction of the total population. On top of that, there is acute danger from mutations of this virus. Against this backdrop, the DG-...

2021-03-11 08:00 1168

First pocket inhaler for Covid-19 and other viral mutations: DG-Nika AG - a new approach to therapy & proactive protection from the pandemic

BUOCHS, Switzerland, March 11, 2021 /PRNewswire/ -- The corona pandemic continues to pose a global threat: To date, it has been possible to vaccinate only a small fraction of the total population. On top of that, there is acute danger from mutations of this virus. Against this backdrop, the DG-Ni...

2021-03-11 08:00 1191

Non-Invasive Liquid Biopsy to Help Cancer Diagnosis Gets CE Certification

LONDON, March 11, 2021 /PRNewswire/ -- Datar Cancer Genetics, a global leader in non-invasive cancer diagnostics, has received Conformité Européenne (CE) Mark for its innovative TruBlood solution, a new paradigm in cancer detection, diagnosis and management. TruBlood is a blood-based, non-invasi...

2021-03-11 07:00 2667

OPTEL Group on Track for Record Year in Asia-Pacific Pharma Sales

OPTEL, a world leader in pharmaceutical track and trace for more than 30 years, expects the current fiscal year to be its best in terms of sales and project delivery to the pharmaceutical industry since the inauguration of its manufacturing plant inGoa, India, in 2016. GOA VELHA, India, March 1...

2021-03-11 04:18 1289

Sofwave Receives Australian Regulatory Approval to Market SUPERB(TM), the Breakthrough Ultrasound Technology Treating Fine Lines & Wrinkles

It is time to position your aesthetic practice at the forefront of innovation! YOQNEAM, Israel, March 10, 2021 /PRNewswire/ -- Sofwave Medical, the emerging leader of energy-based non-invasive, skin treatment aesthetic medical devices, announced today that it received approval fromAustralia's The...

2021-03-10 23:40 1478

Sofwave Receives Australian Regulatory Approval to Market SUPERB™, the Breakthrough Ultrasound Technology Treating Fine Lines & Wrinkles

It is time to position your aesthetic practice at the forefront of innovation! YOQNEAM, Israel, March 10, 2021 /PRNewswire/ -- Sofwave Medical, the emerging leader of energy-based non-invasive, skin treatment aesthetic medical devices, announced today that it received approval fromAustralia's The...

2021-03-10 23:32 1178

Impact Therapeutics Announced First-Patient-Dose of Wee1 Inhibitor IMP7068 in the U.S.

SHANGHAI, March 10, 2021 /PRNewswire/ -- Impact Therapeutics announced today that the first patient was recently dosed in the first-in-human Phase 1 clinical study of Wee1 Inhibitor IMP7068 inthe United States. This is a Phase 1, open-label, multi-center, dose escalation and expansion study to e...

2021-03-10 21:14 1360

Viva Biotech Successfully Held 2021 Partnership Summit -- Novel Drug 2021, the Persistence and Transformation of Start-up Founders

SHANGHAI, March 10, 2021 /PRNewswire/ -- March 2nd-6th, 2021, Viva Biotech successfully hosted the 2021 Partnership Summit. Over 300 attendees joined the Summit, including representatives from global investment institutions, R&D heads from pharmaceutical companies, and business development leader...

2021-03-10 20:18 6514

Viva Biotech Successfully Held 2021 Partnership Summit -- Novel Drug 2021, the Persistence and Transformation of Start-up Founders

Sihuan Pharmaceutical (0460.HK): Be a friend of time, 2021 is the year of turning point

HONG KONG, March 10, 2021 /PRNewswire/ -- Sihuan Pharmaceutical Holdings Group Ltd. plays a pivotal role in the domestic medical industry. It is a leading company inChina's CCV prescription drugs. According to IMS data in 2018, Sihuan Pharmaceutical is well-known on the national hospital prescrip...

2021-03-10 15:02 2876

Arctic Vision Announces Completion of Over US$100 Million Series B Financing to Accelerate Portfolio Expansion, Clinical Development and Commercialization

SHANGHAI, March 9, 2021 /PRNewswire/ -- Arctic Vision, a China-based clinical-stage ophthalmology company focused on developing innovative therapies for pan-ocular diseases, today announced the completion of overUS$100 million Series B financing. The Series B round was led by Loyal Valley Capital...

2021-03-10 08:00 1722

Arctic Vision Announces Completion of Over US$100 Million Series B Financing to Accelerate Portfolio Expansion, Clinical Development and Commercialization

Breaking the Cycle of Opioid Addiction: Alar Presents Positive Interim Results of Long-acting Buprenorphine Injectable (ALA-1000) in Opioid Dependent Patients

* ALA-1000 is the first, three-month slow-release Buprenorphine injection. * Initial results show a low initial burst without dose dumping effect, good safety, and tolerability. * ALA-1000 has the potential to significantly increase compliance and reduce the risk of relapse in patients treat...

2021-03-10 00:00 1404

Hyperice Named to Fast Company's Annual List of the World's Most Innovative Companies for 2021

Recovery Technology Leader Among Top-Ranked in the Sports Category IRVINE, Calif., March 9, 2021 /PRNewswire/ -- Hyperice, the industry leader in recovery technology and pioneer of percussion, vibration, dynamic air compression and thermal technology, has been named toFast Company's prestigious ...

2021-03-09 22:02 2680

Hyperice Named to Fast Company's Annual List of the World's Most Innovative Companies for 2021

Genome and Company signs second clinical trial collaboration and supply agreement (Phase 2) with Merck KGaA, Darmstadt, Germany and Pfizer for immuno-oncology microbiome study

* Genome and Company expands collaboration with Merck KGaA, Darmstadt, Germany and Pfizer for further clinical combination study of GEN-001 in gastric cancers * Establishment of the efficient "clinical development strategy" for the global immuno-oncology microbiome treatment SEOUL, South Korea,...

2021-03-09 22:00 2965

Insilico's Chemistry42 AI system integrated into UCB's drug discovery programs

HONG KONG, March 9, 2021 /PRNewswire/ -- Insilico Medicine, an AI drug discovery company, announced that UCB will integrate Insilico'sChemistry42™ into UCB's internal drug discovery pipeline. UCB's early adoption of Insilico Medicine's proprietary technology will provide UCB's scientists with the...

2021-03-09 22:00 2102

Insilico's Chemistry42 AI system integrated into UCB's drug discovery programs

Alphamab Received U.S. FDA IND Clearance to Initiate A Phase II Pivotal Clinical Trial of KN046 (KN046-205,ENREACH-Thymic) in the U.S.

SUZHOU, China, March 9, 2021 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug application (IND) to initiate an open label, multi-center phase II pivotal clinical study (clinical trial ...

2021-03-09 20:00 3276

Caris' Precision Oncology Alliance Continues to Grow Internationally as it Welcomes Curie Oncology from Singapore

Curie Oncology expands Caris' collaborative network of oncology institutions focused on research into personalized therapies through precision medicine IRVING, Texas, March 9, 2021 /PRNewswire/ -- Caris Life Sciences®, a leading innovator in molecular science and artificial intelligence focused o...

2021-03-09 19:30 1587